ICAD Inc reports results for the quarter ended December 31 - Earnings Summary

• ICAD Inc ICAD.OQ reported a quarterly adjusted loss of 3 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 5 cents. The mean expectation of four analysts for the quarter was for a loss of 5 cents per share. Wall Street expected results to range from -8 cents to -2 cents per share.

• Revenue rose 14.1% to $5.41 million from a year ago; analysts expected $4.83 million.

• ICAD Inc's reported EPS for the quarter was a loss of 3 cents​.

• The company reported a quarterly loss of $854 thousand.

• ICAD Inc shares had risen by 26.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 19.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for ICAD Inc is $3.50

This summary was machine generated from LSEG data March 19 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)